2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease
Published: March 29, 2016
![doctor talking to senior woman](/-/media/PHD-Images/Science-News/d/o/doctor_talking_to_senior_woman.jpg?h=343&iar=0&mh=515&mw=515&w=515)
- This focused update addresses the most current information related to dual antiplatelet use in several areas related to coronary artery disease (CAD).
- This Guideline provides recommendations related to patients with CAD or at risk for developing CAD.
Supporting Materials
- Top Things to Know: ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients with Coronary Artery Disease
- Systematic Review: Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease
- Slide Set (PDF)
- AHA News: New guidelines say blood-thinning therapy should be longer for some, shorter for others
- New Release: Societies Update Guidelines for Dual Antiplatelet Therapy